Treatment of meningioma: An update

Current Neurology and Neuroscience Reports

Volumn 3, Issue 3, 2003, Pages 206-214

  D'Ambrosio, Anthony L ^a   Bruce, Jeffrey N ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; DOXORUBICIN; HYDROXYUREA; IFOSFAMIDE; MESNA; MIFEPRISTONE; RECOMBINANT ALPHA2B INTERFERON; VEROTOXIN; ANTINEOPLASTIC AGENT;

BRAIN ANGIOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; DRUG BINDING; DRUG MECHANISM; DRUG SCREENING; DRUG TOLERABILITY; GENE THERAPY; HUMAN; IMMUNOTHERAPY; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; MICROSURGERY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PATHOLOGY; RADIOSURGERY; REVIEW; SAFETY; SKULL BASE; STEREOTAXIC SURGERY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR REGRESSION; ADOLESCENT; ADULT; AGED; CHILD; MIDDLE AGED; NEUROSURGERY; RECURRENT DISEASE; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHILD; HUMANS; MAGNETIC RESONANCE IMAGING; MENINGIOMA; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RECURRENCE;

EID: 0038605550     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-003-0080-3     Document Type: Review

References (71)

1. Newman SA: Meningiomas: a quest for the optimum therapy. J Neurosurg 1994, 80:191-194.
2. Desai R, Bruce J: Meningiomas of the cranial base. J Neuro-Oncol 1994, 20:255-279.
3. Kokkino AJ, Abdel Aziz KM, Tew JM Jr: Honored guest presentation: contemporary treatment of skull base meningiomas. Clin Neurosurg 2000, 46:554-574.
4. McDermott MW, Wilson CB: Meningiomas. In Neurological Surgery. Edited by Youmans JR. Philadelphia: WB Saunders; 1996:2782-2825.
5. Wara WM: Radiation therapy of meningiomas. Am J Roentgenol Radium Ther Nucl Med 1975, 123:453-458.
6. Arnautovic KI, Al-Mefty O: Primary meningiomas of the jugular fossa. J Neurosurg 2002, 97:12-20.
7. Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous System, edn 5. Baltimore: Williams & Wilkins; 1989.
8. Kliehaus P, Burger PC, Scheithauer BW: Histological Typing of Tumors of the Central Nervous System. New York: Springer-Verlag; 1993.
9. Nakasu S, Li DH, Okabe H, et al.: Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol 2001, 25:472-478.
10. Ho DM, Hsu CY, Ting LT, et al.: Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 2002, 94:1538-1547.
11. Korshunov A, Shishkina L, Golanov A: DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases. Arch Pathol Lab Med 2002, 126:1079-1086.
12. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957, 59:22.
13. Mirimanoff RO, Dosoretz DE, Linggood RM, et al.: Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985, 62:18-24.
14. Nakasu S, Nakasu Y, Nakajima M, et al.: Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 1999, 90:455-462.
15. Engelhard HH: Progress in the diagnosis and treatment of patients with meningiomas. Part I: diagnostic imaging, preoperative embolization. Surg Neurol 2001, 55:89-101.
16. Murtagh R, Linden C: Neuroimaging of intracranial meningiomas. Neurosurg Clin North Am 1994, 5:217-233.
17. Nelson PK, Setton A, Choi IS, et al.: Current status of interventional neuroradiology in the management of meningiomas. Neurosurg Clin North Am 1994, 5:235-259.
18. Chun JY, McDermott MW, Lamborn KR, et al.: Delayed surgical resection reduces intracoperative blood loss for embolized meningiomas. Neurosurgery 2002, 50:1231-1235.
19. Kai Y, Hamada J, Morioka M, et al.: Appropriate interval between embolization and surgery in patients with meningioma. Am J Neuroradiol 2002, 23:139-142.
20. Yamashita J, Handa H, Iwaki K, et al.: Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg Neurol 1980, 14:33-40.
21. Turbin RE, Thompson CR, Kennerdell JS, et al.: A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology 2002, 109:890-899.
22. Nicolato A, Foroni R, Alessandrini F, et al.: The role of Gamma Knife radiosurgery in the management of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 2002, 53:992-1000.
23. Sekhar LN, Wright DC, Richardson R, Monacci W: Petroclival and foramen magnum meningiomas: surgical approaches and pitfalls. J Neuro-Oncol 1996, 29:249-259.
24. Batra PS, Dutra JC, Wiet RJ: Auditory and facial nerve function following surgery for cerebellopontine angle meningiomas. Arch Otolaryngol Head Neck Surg 2002, 128:369-374.
25. Pieper DR, Al-Mefty O: Management of intracranial meningiomas secondarily involving the infratemporal fossa: radiographic characteristics, pattern of tumor invasion, and surgical implications. Neurosurgery 1999, 45:231-237.
26. Olivero WC, Lister JR, Elwood PW: The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 1995, 83:222-224.
27. Kuratsu J, Kochi M, Ushio Y: Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 2000, 92:766-770.
28. Zwerdling T, Dothage J: Meningiomas in children and adolescents. J Pediatr Hematol Oncol 2002, 24:199-204.
29. Baumgartner JE, Sorenson JM: Meningioma in the pediatric population. J Neuro-Oncol 1996, 29:223-228.
30. Lund-Johansen M, Scheie D, Muller T, et al.: Neurosurgical treatment of meningiomas in children and young adults. Childs Nerv Syst 2001, 17:719-723.
31. Longstreth WT Jr, Dennis LK, McGuire VM, et al.: Epidemiology of intracranial meningioma. Cancer 1993, 72:639-648.
32. Harrison MJ, Wolfe DE, Lau TS, et al.: Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature. J Neurosurg 1991, 75:564-574.
33. Strojan P, Popovic M, Jereb B: Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature. Int J Radiat Oncol Biol Phys 2000, 48:65-73.
34. Akagami R, Napolitano M, Sekhar LN: Patient-evaluated outcome after surgery for basal meningiomas. Neurosurgery 2002, 50:941-948.
35. Ciric I, Rosenblatt S: Suprasellar meningiomas. Neurosurgery 2001, 49:1372-1377.
36. DeMonte F: Surgical treatment of anterior basal meningiomas. J Neuro-Oncol 1996, 29:239-248.
37. Awad IA, Kalfas I, Hahn JF, Little JR: Intracranial meningiomas in the aged: surgical outcome in the era of computed tomography. Neurosurgery 1989, 24:557-560.
38. Mathiesen T, Lindquist C, Kihlstrom L, et al.: Recurrence of cranial base meningiomas. Neurosurgery 1996, 39:2-7.
39. Fahlbusch R, Schott W: Pterional surgery of meningiomas of the tuberculum sellae and planum sphenoidale: surgical results with special consideration of ophthalmological and endocrinological outcomes. J Neurosurg 2002, 96:235-243.
40. Nakaya K, Hayashi M, Nakamura S, et al.: Low-dose radiosurgery for meningiomas. Stereotact Funct Neurosurg 1999, 72(suppl 1):67-72.
41. Black PM, Villavicencio AT, Rhouddou C, Loeffler JS: Aggressive surgery and focal radiation in the management of meningiomas of the skull base: preservation of function with maintenance of local control. Acta Neurochir (Wien) 2001, 143:555-562.
42. Lunsford LD: Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal? J Neurosurg 1994, 80:187-190.
43. Goldsmith BJ, Wara WM, Wilson CB, Larson DA: Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994, 80:195-201.
44. Milosevic MF, Frost PJ, Laperrier NJ, et al.: Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 1996, 34:817-822.
45. Miralbell R, Linggod RM, de la Monte S, et al.: The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neuro-Oncol 1992, 13:157-164.
46. Hodes JE, Sanders M, Patel P, Patchell RA: Radiosurgical management of meningiomas. Stereotact Funct Neurosurg 1996, 66:15-18.
47. Hakim R, Alexander E 3rd, Loeffler JS, et al.: Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery 1998, 42:446-453.
48. Maor MH: Radiotherapy for meningiomas. J Neuro-Oncol 1996, 29:261-267.
49. Eustacchio S, Trummer M, Fuchs I, et al.: Preservation of cranial nerve function following Gamma Knife radiosurgery for benign skull base meningiomas: experience in 121 patients with follow-up of 5 to 9.8 years. Acta Neurochir 2002, 84(suppl):71-76.
50. Uy NW, Woo SY, Teh BS, et al.: Intensity-modulated radiation therapy (IMRT) for meningioma. Int J Radiat Oncol Biol Phys 2002, 53:1265-1270.
51. Jalali R, Loughrey C, Baumer B, et al.: High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location. Clin Oncol (R Coll Radiol) 2002, 14:103-109.
52. Lee JY, Niranjan A, McInerney J, et al.: Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 2002, 97:65-72.
53. Iwai Y, Yamanaka K, Nakajima H: The treatment of skull base meningiomas - combining surgery and radiosurgery. J Clin Neurosci 2001, 8(6):528-533.
54. Aichholzer M, Bertalanffy A, Dietrich W, et al.: Gamma knife radiosurgery of skull base meningiomas. Acta Neurochir (Wien) 2000, 142:647-652.
55. Vernimmen FJ, Harris JK, Wilson JA, et al.: Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 2001, 49:99-105.
56. Nicolato A, Foroni R, Pellegrino M, et al.: Gamma knife radiosurgery in meningiomas of the posterior fossa. Experience with 62 treated lesions. Min Invasive Neurosurg 2001, 44:211-217.
57. Stafford SL, Pollock BE, Foote RL, et al.: Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001, 49:1029-1037.
58. LeMay DR, Bucci MN, Farhat SM: Malignant transformation of recurrent meningioma with pulmonary metastases. Surg Neurol 1989, 31:365-368.
59. Stewart DJ, Dahrouge S, Wee M, et al.: Intraarterial cisplatin plus intravenous doxorubicin for inoperable recurrent meningiomas. J Neuro-Oncol 1995, 24:189-194.
60. Bernstein M, Villamil A, Davidson G, Erlichman C: Necrosis in a meningioma following systemic chemotherapy. Case report. J Neurosurg 1994, 81:284-287.
61. Kyritsis AP: Chemotherapy for meningiomas. J Neuro-Oncol 1996, 29:269-272.
62. Mason WP, Gentilil F, MacDonald DR, et al.: Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg 2002, 97:341-346.
63. Newton HB, Slivka MA, Stevens C: Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neuro-Oncol 2000, 49:165-170.
64. Rosenthal MA, Ashley DL, Cher L: Treatment of high risk or recurrent meningiomas with hydroxyurea. J Clin Neurosci 2002, 9:156-158.
65. Kaba SE, DeMonte F, Bruner JM, et al.: The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery 1997, 40:271-275.
66. Schoenberg BS, Christine BW, Whisnant JP: Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 1975, 25:705-712.
67. Schrell UM, Adams EF, Fahlbusch R, et al.: Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 1990, 73:743-749.
68. Magdelenat H, Pertuiset BF, Poisson M, et al.: Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases. Acta Neurochir (Wien) 1982, 64:199-213.
69. Adams EF, Schrell UM, Fahlbusch R, Thierauf P: Hormonal dependency of cerebral meningiomas. Part 2: In vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas. J Neurosurg 1990, 73:750-755.
70. Dirven CM, Grill J, Lamfers ML, et al.: Gene therapy for meningioma: improved gene delivery with targeted adenoviruses. J Neurosurg 2002, 97:441-449.
71. Salhia B, Rutka JT, Lingwood C, et al.: The treatment of malignant meningioma with verotoxin. Neoplasia 2002, 4:304-311.